Vipul Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 15 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 11-12-2024
- Satisfied Charges ₹ 6.50 Cr
as on 11-12-2024
- Revenue -20.39%
(FY 2022)
- Profit -52.76%
(FY 2022)
- Ebitda -692.86%
(FY 2022)
- Net Worth 5.31%
(FY 2022)
- Total Assets -32.14%
(FY 2022)
About Vipul Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹6.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parvinder Kansal and Sonia Kansal serve as directors at the Company.
- CIN/LLPIN
U24232DL2009PTC196994
- Company No.
196994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Vipul Pharma Private Limited offer?
Vipul Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Antifungal Injection, Tablet & Syrup, Brain & Nervous System Drugs, Antiepileptic Drugs, Common Disease Medicines, Psoriasis Ointment, Nutraceuticals & Dietary Supplements, Nutraceuticals, Antibacterial Drugs.
Who are the key members and board of directors at Vipul Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvinder Kansal  | Whole-Time Director | 16-Dec-2009 | Current |
| Sonia Kansal | Whole-Time Director | 08-Aug-2017 | Current |
Financial Performance of Vipul Pharma.
Vipul Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.39% decrease. The company also saw a substantial fall in profitability, with a 52.76% decrease in profit. The company's net worth moved up by a moderate rise of 5.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vipul Pharma?
In 2021, Vipul Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Aug 2020 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 05 Nov 2018 | ₹2.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 20 Apr 2017 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Vipul Pharma?
Unlock and access historical data on people associated with Vipul Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vipul Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipul Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
